Yan Wang

Publication Activity (10 Years)

Years Active: 2022-2023
Publications (10 Years): 4

Top Topics

Diffuse Large B Cell Lymphoma

Acute Lymphoblastic Leukemia

Top Venues

Blood cancer journal

Clinical cancer research : an official journal of the American Association for Cancer Research

Nutrition in clinical practice : official publication of the American Society for Parenteral and Enteral Nutrition

This page only lists publications with an associated author ORCID identifier.

Publications

Vinod Pullarkat, Lisa S Chen, Joycelynne Palmer, Jianying Zhang, Timothy W Synold, Ralf Buettner, Le Xuan Truong Nguyen, Guido Marcucci, Ni-Chun Tsai, Yan Wang, James O'Hearn, Varsha Gandhi, Steven T Rosen
A phase 1 trial of 8-chloro-adenosine in relapsed/refractory acute myeloid leukemia: An evaluation of safety and pharmacokinetics. Cancer (2023)
Ibrahim Aldoss, Samer K Khaled, Yan Wang, Xiuli Wang, Joycelynne Palmer, Mary C Clark, Jamie R Wagner, Jinny Paul, Vibhuti Vyas, Christine E Brown, Stephen J Forman
Donor-derived CD19-targeted chimeric antigen receptor T cells in adult transplant recipients with relapsed/refractory acute lymphoblastic leukemia. Blood cancer journal 13 (1) (2023)
Hua Xie, Li Hua Qiao, Yue Zhao, Zijie Yan, Huijin Bai, Yan Wang, Tingting Ye, Jun Yu, Qin Du, Jianqin Sun
Nutrition education with or without oral nutrition supplements has contrasting effects on nutrition status in older adults: A randomized controlled study. Nutrition in clinical practice : official publication of the American Society for Parenteral and Enteral Nutrition (2022)
Ibrahim Aldoss, Samer K Khaled, Xiuli Wang, Joycelynne Palmer, Yan Wang, Jamie R Wagner, Mary C Clark, Jennifer Simpson, Jinny Paul, Vibhuti Vyas, Sheng-Hsuan Chien, Anthony S Stein, Vinod A Pullarkat, Amandeep Salhotra, Monzr M Al Malki, Sandra H Thomas, L Elizabeth Elizabeth Budde, Guido Marcucci, Christine E Brown, Stephen J Forman
Favorable Activity and Safety Profile of Memory-Enriched CD19-Targeted Chimeric Antigen Receptor T Cell Therapy in Adults with high-risk Relapsed/Refractory ALL. Clinical cancer research : an official journal of the American Association for Cancer Research (2022)